132 related articles for article (PubMed ID: 38242492)
1. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy.
Tomkins-Netzer O; Niederer R; Greenwood J; Fabian ID; Serlin Y; Friedman A; Lightman S
Prog Retin Eye Res; 2024 Mar; 99():101245. PubMed ID: 38242492
[TBL] [Abstract][Full Text] [Related]
2. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia.
Nakamura N; Honjo M; Yamagishi R; Sakata R; Watanabe S; Aihara M
Exp Eye Res; 2023 Dec; 237():109691. PubMed ID: 37884204
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
4. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture.
Cunha-Vaz J
Ophthalmologica; 2017; 237(1):1-10. PubMed ID: 28152535
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
6. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
Luna JD; Chan CC; Derevjanik NL; Mahlow J; Chiu C; Peng B; Tobe T; Campochiaro PA; Vinores SA
J Neurosci Res; 1997 Aug; 49(3):268-80. PubMed ID: 9260738
[TBL] [Abstract][Full Text] [Related]
7. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation.
Kokona D; Ebneter A; Escher P; Zinkernagel MS
J Neuroinflammation; 2018 Dec; 15(1):340. PubMed ID: 30541565
[TBL] [Abstract][Full Text] [Related]
8. Immune Privilege: The Microbiome and Uveitis.
Mölzer C; Heissigerova J; Wilson HM; Kuffova L; Forrester JV
Front Immunol; 2020; 11():608377. PubMed ID: 33569055
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
[TBL] [Abstract][Full Text] [Related]
10. Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown.
Haurigot V; Villacampa P; Ribera A; Llombart C; Bosch A; Nacher V; Ramos D; Ayuso E; Segovia JC; Bueren JA; Ruberte J; Bosch F
J Biol Chem; 2009 Aug; 284(34):22961-9. PubMed ID: 19473988
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
13. The blood-retinal barriers.
Cunha-Vaz JG
Doc Ophthalmol; 1976 Oct; 41(2):287-327. PubMed ID: 1009819
[TBL] [Abstract][Full Text] [Related]
14. Intravenously administered anti-recoverin antibody alone does not pass through the blood-retinal barrier.
Kim JH; Kim JH; Kim DH; Park WY; Kim KW; Yu YS
Korean J Ophthalmol; 2011 Jun; 25(3):189-95. PubMed ID: 21655045
[TBL] [Abstract][Full Text] [Related]
15. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat.
Ellis EA; Guberski DL; Somogyi-Mann M; Grant MB
Free Radic Biol Med; 2000 Jan; 28(1):91-101. PubMed ID: 10656295
[TBL] [Abstract][Full Text] [Related]
16. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.
Titchenell PM; Lin CM; Keil JM; Sundstrom JM; Smith CD; Antonetti DA
Biochem J; 2012 Sep; 446(3):455-67. PubMed ID: 22721706
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.
Xu H; Dawson R; Crane IJ; Liversidge J
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2487-94. PubMed ID: 15980240
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous panuveitis associated with Hodgkin lymphoma: A case report with review of the literature.
Alshamrani AA; Alsarhani WK; Aljasser AA; Rubio-Caso MJ
Eur J Ophthalmol; 2022 Jan; 32(1):NP102-NP108. PubMed ID: 33153312
[TBL] [Abstract][Full Text] [Related]
20. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
